Health care-associated infections - an overview

Mainul Haque, Massimo Sartelli, Judy McKimm, Muhamad Abu Bakar, Mainul Haque, Massimo Sartelli, Judy McKimm, Muhamad Abu Bakar

Abstract

Health care-associated infections (HCAIs) are infections that occur while receiving health care, developed in a hospital or other health care facility that first appear 48 hours or more after hospital admission, or within 30 days after having received health care. Multiple studies indicate that the common types of adverse events affecting hospitalized patients are adverse drug events, HCAIs, and surgical complications. The US Center for Disease Control and Prevention identifies that nearly 1.7 million hospitalized patients annually acquire HCAIs while being treated for other health issues and that more than 98,000 patients (one in 17) die due to these. Several studies suggest that simple infection-control procedures such as cleaning hands with an alcohol-based hand rub can help prevent HCAIs and save lives, reduce morbidity, and minimize health care costs. Routine educational interventions for health care professionals can help change their hand-washing practices to prevent the spread of infection. In support of this, the WHO has produced guidelines to promote hand-washing practices among member countries.

Keywords: catheter-associated urinary tract infections; central line-associated bloodstream infections; health care-associated infections; surgical site infections; ventilator-associated pneumonia.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Collins AS. Preventing Health Care-Associated Infections. In: Hughes RG, editor. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008. Apr, [Accessed April 1, 2018]. Chapter 41. Available from:
    1. Revelas A. Healthcare - associated infections: A public health problem. Niger Med J. 2012;53(2):59–64.
    1. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324(6):370–376.
    1. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377–384.
    1. Garrouste-Orgeas M, Philippart F, Bruel C, Max A, Lau N, Misset B. Overview of medical errors and adverse events. Ann Intensive Care. 2012;2(1):2.
    1. Parameswaran Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions –the need for a prediction tool. Clin Interv Aging. 2016;11:497–505.
    1. Desikan R, Krauss MJ, Dunagan WC, et al. Reporting of Adverse Drug Events: Examination of a Hospital Incident Reporting System. In: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings) Rockville (MD): Agency for Healthcare Research and Quality (US); 2005. [Accessed April 1, 2018]. Available from:
    1. Klevens RM, Edwards JR, Richards CL. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–166.
    1. Agency for Healthcare Research and Quality [webpage on the Internet] Patient safety primers: healthcare-associated infections. 2012. [Accessed April 3, 2018]. Available from: .
    1. Danasekaran R, Mani G, Annadurai K. Prevention of healthcare-associated infections: protecting patients, saving lives. Int J Community Med Public Health. 2014;1(1):67–68.
    1. World Alliance for Patient Safety [webpage on the Internet] The Global Patient Safety Challenge 2005–2006 “Clean Care is Safer Care.”. Geneva: WHO; 2005. [Accessed April 4, 2018]. Available from:
    1. Vincent J-L. Nosocomial infections in adult intensive-care units. Lancet. 2003;361(9374):2068–2077.
    1. Kim JM, Park ES, Jeong JS, et al. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control. 2000;28(6):454–458.
    1. Nuvials X, Palomar M, Alvarez-Lerma F, et al. Health-care associated infections. Patient characteristics and influence on the clinical outcome of patients admitted to ICU. Envin-Helics registry data. Intensive Care Med Exp. 2015;3(Suppl 1):A82.
    1. Klavs I, Bufon Lužnik T, Skerl M, et al. Prevalance of and risk factors for hospital-acquired infections in Slovenia-results of the first national survey, 2001. J Hosp Infect. 2003;54(2):149–157.
    1. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. The French Prevalence Survey Study Group. J Hosp Infect. 2005;60(1):40–45.
    1. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996 J Hosp Infect. 2000;46(3):186–193.
    1. Gikas A, Pediaditis J, Papadakis JA, et al. Greek Infection Control Network Prevalence study of hospital-acquired infections in 14 Greek hospitals: planning from the local to the national surveillance level. J Hosp Infect. 2002;50(4):269–275.
    1. di Pietrantonj C, Ferrara L, Lomolino G. Multicenter study of the prevalence of nosocomial infections in Italian hospitals. Infect Control Hosp Epidemiol. 2004;25(1):85–87.
    1. Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals–overview of the results. J Hosp Infect. 1996;32(3):175–190.
    1. McLaws ML, Taylor PC. The Hospital Infection Standardised Surveillance (HISS) programme: analysis of a two-year pilot. J Hosp Infect. 2003;53(4):259–267.
    1. WHO Healthcare-associated infections. Fact Sheet. [Accessed April 1, 2018]. Available from: .
    1. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005-2013. MMWR Suppl. 2014;63(4):3–27.
    1. McDermid RC, Stelfox HT, Bagshaw SM. Frailty in the critically ill: a novel concept. Crit Care. 2011;15(1):301.
    1. Chernow B. Variables affecting outcome in critically ill patients. Chest. 1999;115(5 Suppl):S71–S76.
    1. Sokol D. A guide to the Hippocratic Oath. 2008. [Accessed April 3, 2018]. Available from: .
    1. Beveridge WIB. The art of scientific investigation. Chapter IX. Revised Edition. WW Norton & Company; New York: 1957. [Accessed April 4, 2018]. p. 114. Available from: .
    1. McCannon CJ, Berwick DM, Massoud MR. The science of large-scale change in global health. JAMA. 2007;298(16):1937–1939.
    1. McCannon CJ, Hackbarth AD, Griffin FA. Miles to go: an introduction to the 5 Million Lives Campaign. Jt Comm J Qual Patient Saf. 2007;33(8):477–484.
    1. Janine Benyus. Brainy Quote. 2018. [Accessed April 3, 2018]. Available from: .
    1. Noakes TD, Borresen J, Hew-Butler T, Lambert MI, Jordaan E. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review. Epidemiol Infect. 2008;136(1):1–9.
    1. Sydnor ERM, Perl TM. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clin Microbiol Rev. 2011;24(1):141–173.
    1. Magill SS, Edwards JR, Bamberg W, et al. Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208.
    1. Magill SS, Hellinger W, Cohen J, et al. Prevalence of Healthcare-Associated Infections in Acute Care Hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol. 2012;3(3):283–291.
    1. Magill SS, Wilson LE, Thompson DL, et al. Emerging Infections Program Hospital Prevalence Survey Team Reduction in the Prevalence of Healthcare-Associated Infections in US. Acute Care Hospitals, 2015 vs 2011. Open Forum Infect Dis. 2017;4(Suppl 1):S49.
    1. Cai Y, Venkatachalam I, Tee NW, et al. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey. Clin Infect Dis. 2017;64(Suppl 2):S61–S67.
    1. Cassini A, Plachouras D, Eckmanns T, et al. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLoS Med. 2016;13(10):e1002150.
    1. Kritsotakis EI, Kontopidou F, Astrinaki E, Roumbelaki M, Ioan-nidou E, Gikas A. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infect Drug Resist. 2017;10:317–328.
    1. Ling ML, Apisarnthanarak A, Madriaga G. The Burden of Healthcare-Associated Infections in Southeast Asia: A Systematic Literature Review and Meta-analysis. Clin Infect Dis. 2015;60(11):1690–1699.
    1. Askarian M, Yadollahi M, Assadian O. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran. J Infect Public Health. 2012;5(2):169–176.
    1. Tagoe DN, Desbordes KK. Investigating potential sources of transmission of healthcare-associated infections in a regional hospital, Ghana. Int J Appl Basic Med Res. 2012;2(1):20–24.
    1. Santajit S, Indrawattana N. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. Biomed Res Int. 2016;2016:2475067.
    1. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079–1081.
    1. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
    1. Sievert DM, Ricks P, Edwards JR, et al. National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.
    1. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12.
    1. World Health Organization . WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care Chapter 3. Geneva: World Health Organization; 2009. [Accessed September 4, 2018]. The burden of health care-associated infection. Available from:
    1. Amin AN, Deruelle D. Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA. Future Microbiol. 2015;10(6):1049–1062.
    1. Galani I, Souli M, Daikos GL, et al. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother. 2012;24(4):191–194.
    1. Landman D, Kelly P, Bäcker M, et al. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother. 2011;66(2):332–334.
    1. Cass RT, Brooks CD, Havrilla NA, et al. Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects. Antimicrob Agents Chemother. 2011;55(12):5874–5880.
    1. Kumari J, Shenoy SM, Baliga S, Chakrapani M, Bhat GK. Healthcare-Associated Methicillin-Resistant Staphylococcus aureus: Clinical characteristics and antibiotic resistance profile with emphasis on macrolide-lincosamide-streptogramin B resistance. Sultan Qaboos Univ Med J. 2016;16(2):e175–e181.
    1. Bagheri Nejad S, Allegranzi B, Syed SB, Ellis B, Pittet D. Health-care-associated infection in Africa: a systematic review. Bull World Health Organ. 2011;89(10):757–765.
    1. Khan HA, Baig FK, Mehboob R. Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478–482.
    1. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.
    1. Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301.
    1. Messina AF, Berman DM, Ghazarian SR, et al. The management and outcome of spinal implant-related infections in pediatric patients: a retrospective review. Pediatr Infect Dis J. 2014;33(7):720–723.
    1. Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1):67.
    1. Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High Prevalence and Endemicity of Multidrug Resistant Acinetobacter spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India. J Pathog. 2018;2018(2):9129083.
    1. French Society for Hospital Hygiene Surveillance and Prevention of healthcare associated infections. 2010. [Accessed April 4, 2018]. Available from: .
    1. US Department of Health & Human Services [webpage on the Inter-net] Centers for Disease Control and Prevention Types of Healthcare-associated Infections. 2014. [Accessed April 4, 2018]. Available from: .
    1. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41(11):1591–1598.
    1. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol. 2000;21(6):375–380.
    1. U.S. Department of Health & Human Services Centers for Disease Control and Prevention. Vital Signs: Central Line-Associated Blood Stream Infections - United States, 2001, 2008, and 2009. MMWR. 2011;60:243–248.
    1. Atilla A, Doğanay Z, Kefeli Çelik H, Demirağ MD, S Kiliç S. Central line-associated blood stream infections: characteristics and risk factors for mortality over a 5.5-year period. Turk J Med Sci. 2017;47(2):646–652.
    1. Lin KY, Cheng A, Chang YC, et al. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017;50(3):339–348.
    1. Advani S, Reich NG, Sengupta A, Gosey L, Milstone AM. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis. 2011;52(9):1108–1115.
    1. Patchen Dellinger E. Surgical Site Infections. In: Jong Elaine C, Stevens Dennis L., editors. Netter’s Infectious Diseases. 1st ed. Philadelphia: Elsevier Saunders; 2012. 2012. pp. 295–298.
    1. US Department of Health & Human Services Centers for Disease Control and Prevention National and State Healthcare-Associated Infections Progress report is based on 2014 data. 2016. [Accessed April 5, 2018]. Available from: .
    1. Hagel S, Ludewig K, Frosinski J, et al. Effectiveness of a hospital-wide educational programme for infection control to reduce the rate of health-care associated infections and related sepsis (ALERTS)– methods and interim results. Dtsch Med Wochenschr. 2013;138(34–35):1717–1722. German.
    1. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70(Suppl 2):3–10.

    1. Annual epidemiological report: Reporting on 2011 surveillance data and 2012 epidemic intelligence data ECDC 2013

    1. Centers for Disease Control and Prevention Surgical Site Infection (SSI) Event. 2018. [Accessed September 2, 2018]. Available from: .
    1. Martin ET, Kaye KS, Knott C, et al. Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):88–99.
    1. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606–608.
    1. Monge Jodra V, Sainz de Los Terreros Soler L, Diaz-Agero Perez C, Saa Requejo CM, Plana Farras N. Excess length of stay attributable to surgical site infection following hip replacement: a nested case-control study. Infect Control Hosp Epidemiol. 2006;27(12):1299–1303.
    1. Kusachi S, Kashimura N, Konishi T, et al. Length of stay and cost for surgical site infection after abdominal and cardiac surgery in Japanese hospitals: multi-center surveillance. Surg Infect (Larchmt) 2012;13(4):257–265.
    1. Tsai DM, Caterson EJ. Current preventive measures for health-care associated surgical site infections: a review. Patient Saf Surg. 2014;8(1):42.
    1. Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg. 2006;29(4):456–460.
    1. Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112(3):666–675.
    1. Joseph L, Jeanmonod RK. Delayed presentation of deep sternal wound infection. West J Emerg Med. 2014;15(2):134–136.
    1. Rupprecht L, Schmid C. Deep Sternal Wound Complications: An Overview of Old and New Therapeutic Options. Open J Cardiovas Sur. 2013;6:9–19.
    1. Hashemzadeh K, Hashemzadeh S. In-hospital outcomes of delayed sternal closure after open cardiac surgery. J Card Surg. 2009;24(1):30–33.
    1. Al-Mulhim FA, Baragbah MA, Sadat-Ali M, Alomran AS, Azam MQ. Prevalence of Surgical Site Infection in Orthopedic Surgery: A 5-year Analysis. Int Surg. 2014;99(3):264–268.
    1. Spagnolo AM, Ottria G, Amicizia D, Perdelli F, Cristina ML. Operating theatre quality and prevention of surgical site infections. J Prev Med Hyg. 2013;54(3):131–137.
    1. Cristina ML, Sartini M, Schinca E, Ottria G, Spagnolo AM. Operating room environment and surgical site infections in arthroplasty procedures. J Prev Med Hyg. 2016;57(3):E142–E148.
    1. Li GQ, Guo FF, Ou Y, Dong GW, Zhou W. Epidemiology and outcomes of surgical site infections following orthopedic surgery. Am J Infect Control. 2013;41(12):1268–1271.
    1. Watanabe A, Kohnoe S, Shimabukuro R, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today. 2008;38(5):404–412.
    1. Smyth ET, Emmerson AM. Surgical site infection surveillance. J Hosp Infect. 2000;45(3):173–184.
    1. Aga E, Keinan-Boker L, Eithan A, Mais T, Rabinovich A, Nassar F. Surgical site infections after abdominal surgery: incidence and risk factors. A prospective cohort study. Infect Dis (Lond) 2015;7(11):761–767.
    1. Duerden B, Fry C, Johnson AP, Wilcox MH. The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England. Open Forum Infect Dis. 2015;2(2):ofv035.
    1. Cristea OM, Zlatian OM, Dinescu SN, et al. A comparative study on antibiotic resistance of Klebsiella strains from surgical and intensive care wards. Curr Heal Sci J. 2016;42(2):169–179.
    1. Jevons MP. “Celbenin” – resistant Staphylococci. BMJ. 1961;1(5219):124–125.
    1. Byrd KK, Holman RC, Bruce MG, et al. Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis. 2009;49(7):1009–1015.
    1. Cimolai N. Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned. Can J Microbiol. 2010;56(2):89–120.
    1. Dulon M, Haamann F, Peters C, Schablon A, Nienhaus A. MRSA prevalence in European healthcare settings: a review. BMC Infect Dis. 2011;11(1):138.
    1. Maehara Y, Shirabe K, Kohnoe S, et al. Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepatobiliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial. Surg Today. 2017;47(9):1060–1071.
    1. Feng C, Sidhwa F, Cameron DB, Glass C, Rangel SJ. Rates and burden of surgical site infections associated with pediatric colorectal surgery: insight from the National Surgery Quality Improvement Program. J Pediatr Surg. 2016;51(6):970–974.
    1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49(2):53–70.
    1. Tenke P, Mezei T, Bőde I, Köves B. Catheter-associated Urinary Tract Infections. Euro Urol Suppl. 2017;16(4):138–143.
    1. Stamm WE. Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and prevention. Am J Med. 1991;91(3):S65–S71.
    1. Elvy J, Colville A. Catheter associated urinary tract infection: what is it, what causes it and how can we prevent it? J Infect Prev. 2009;10(2):36–41.
    1. Leelakrishna P, Karthik Rao B. A study of risk factors for catheter associated urinary tract infection. Int J Adv Med. 2018;5(2):334–339.
    1. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated Catheter-Associated Urinary Tract Infections Due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26–59.
    1. Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3(1):23.
    1. Nicolle LE. Catheter-related urinary tract infection. Drugs Aging. 2005;22(8):627–639.
    1. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74(2):131–136.
    1. Barford JMT, Coates ARM. The pathogenesis of catheter-associated urinary tract infection. J Infect Prev. 2009;10(2):50–56.
    1. Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. How Biofilms Evade Host Defenses. Microbiol Spectr. 2015;3(3):1–10.
    1. Chant C, Smith OM, Marshall JC, Friedrich JO. Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Med. 2011;39(5):1167–1173.
    1. Mitchell BG, Ferguson JK, Anderson M, Sear J, Barnett A. Length of stay and mortality associated with healthcare-associated urinary tract infections: a multi-state model. J Hosp Infect. 2016;93(1):92–99.
    1. Haniffa R, Isaam I, De Silva AP, Dondorp AM, De Keizer NF. Performance of critical care prognostic scoring systems in low and middle-income countries: a systematic review. Crit Care. 2018;22(1):18.
    1. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887–892.
    1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903.
    1. McEachern R, Campbell GD., Jr Hospital-acquired pneumonia: epidemiology, etiology, and treatment. Infect Dis Clin North Am. 1998;12(3):761–779.
    1. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637–657.
    1. Hunter JD. Ventilator associated pneumonia. BMJ. 2012;344:e3325.
    1. Craven DE, Hjalmarson KI. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Clin Infect Dis. 2010;51(Suppl 1):S59–S66.
    1. American Thoracic Society, Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416.
    1. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637–657.
    1. Kalanuria AA, Ziai W, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208.
    1. Skrupky LP, Mcconnell K, Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med. 2012;40(1):281–284.
    1. Rosenthal VD, Maki DG, Jamulitrat S, et al. INICC Members International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010;38(2):95–104.e2.
    1. Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control. 2008;36(4 Suppl):S93–S100.
    1. Mathai AS, Phillips A, Isaac R. Ventilator-associated pneumonia: A persistent healthcare problem in Indian Intensive Care Units. Lung India. 2016;33(5):512–516.
    1. Rello J, Ollendorf DA, Oster G, et al. VAP Outcomes Scientific Advisory Group Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2121.
    1. Chaudhury A, Rani AS, Kalawat U, Sumant S, Verma A, Venkataramana B. Antibiotic resistance & pathogen profile in ventilator-associated pneumonia in a tertiary care hospital in India. Indian J Med Res. 2016;144(3):440–446.
    1. Chi SY, Kim TO, Park CW, et al. Bacterial Pathogens of Ventilator Associated Pneumonia in a Tertiary Referral Hospital. Tuberc Respir Dis. 2012;73(1):32–37.
    1. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care. 2008;23(1):5–10.
    1. Humphreys H, Newcombe RG, Enstone J, et al. Hospital Infection Society Steering Group Four country healthcare-associated infection prevalence survey: pneumonia and lower respiratory tract infections. J Hosp Infect. 2010;74(3):266–270.
    1. Yan T, Li Y, Sun Y, et al. Hospital-acquired lower respiratory tract infections among high risk hospitalized patients in a tertiary care teaching hospital in China: An economic burden analysis. J Infect Public Health. 2018;11(4):507–513.
    1. Pradhan NP, Bhat SM, Ghadage DP. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality. J Assoc Physicians India. 2014;62(10):18–21.
    1. Chughtai M, Gwam CU, Mohamed N, et al. The Epidemiology and Risk Factors for Postoperative Pneumonia. J Clin Med Res. 2017;9(6):466–475.
    1. Kazaure HS, Martin M, Yoon JK, Wren SM. Long-term results of a postoperative pneumonia prevention program for the inpatient surgical ward. JAMA Surg. 2014;149(9):914–918.
    1. Rello J, Ollendorf DA, Oster G, et al. VAP Outcomes Scientific Advisory Group Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2121.
    1. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312–1317.
    1. Cole M. Patient safety and healthcare-associated infection. Br J Nurs. 2011;201122(17):1122–1126.
    1. WHO . Report on the Burden of Endemic Health Care-Associated Infection Worldwide. WHO Press, WHO; Geneva, Switzerland: 2011. [Accessed April 19, 2018]. Available from: .
    1. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–S89.
    1. Graves N, Weinhold D, Tong E, et al. Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28(3):280–292.
    1. Stone PW. Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res. 2009;9(5):417–422.
    1. Head MG, Fitchett JR, Holmes AH, Atun R. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010. J Hosp Infect. 2014;87(2):84–91.
    1. Glance LG, Stone PW, Mukamel DB, Dick AW. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg. 2011;146(7):794–801.
    1. Scott RD. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention. 2009. [Accessed April 19, 2018]. Available from: .
    1. Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA. 2005;293(19):2384–2390.
    1. Thibault R, Makhlouf AM, Kossovsky MP, et al. Healthcare-associated infections are associated with insufficient dietary intake: an observational cross-sectional study. PLoS One. 2015;10(4):e0123695.
    1. Anderson RN. Deaths: leading causes for 1999. Natl Vital Stat Rep. 2001;49(11):1–87.
    1. Rosenberg A. Hand Hygiene Barriers faced by Health Care Workers in The Gambia: A Health Belief Model Approach [master’s thesis] Södertörn University, School of Natural Sciences, Technology and Environmental Studies; Sweden: 2016. [Accessed September 3, 2018]. .
    1. Pittet D, Allegranzi B, Sax H, et al. WHO Global Patient Safety Challenge, World Alliance for Patient Safety Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis. 2006;6(10):641–652.
    1. Voss A, Widmer AF. No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect Control Hosp Epidemiol. 1997;18(3):205–208.
    1. Widmer AF, Conzelmann M, Tomic M, Frei R, Stranden AM. Introducing alcohol-based hand rub for hand hygiene: the critical need for training. Infect Control Hosp Epidemiol. 2007;28(1):50–54.
    1. Felembam O, John WS, Shaban RZ. Hand hygiene practices of home visiting community nurses: perceptions, compliance, techniques, and contextual factors of practice using the World Health Organization’s “five moments for hand hygiene”. Home Healthc Nurse. 2012;30(3):152–160.
    1. World Health Organization [webpage on the Internet] My 5 Moments for Hand Hygiene. Infection prevention and control. 2009. [Accessed September 3, 2018]. Available from:
    1. Centers for Disease Control and Prevention [webpage on the Internet] Healthcare Infection Control Practices Advisory Committee (HICPAC) 2018. [AccessedSeptember 4, 2018]. Available from: .
    1. Royal College of Nursing Good practice in infection prevention and control. Guidance for nursing staff. 2005. [Accessed April 19, 2018]. Available from: .
    1. McLaws ML. The relationship between hand hygiene and health care-associated infection: it’s complicated. Infect Drug Resist. 2015;8:7–18.
    1. Hynes N. A Hand Hygiene Education and Training Improvement Strategy in an Acute Hospital Setting [master’s dissertation] Dublin, Ireland: Royal College of Surgeons in Ireland; 2015. [Accessed April 19, 2018]. Available from: .
    1. Gould DJ, Moralejo D, Drey N, Chudleigh JH. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev. 2010;9(9):CD005186.
    1. Gould DJ, Moralejo D, Drey N, Chudleigh JH, Taljaard M. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev. 2017;9:CD005186.
    1. Roberts JA, Cookson BD. The management, prevention, and control of Healthcare Associated Infections in Acute NHS Trusts in England – International Comparison and Review. 2009. [Accessed April 19, 2018]. Available from: .
    1. Cole M. Social Construction of Hand Hygiene As a Simple Measure to Prevent Health Care Associated Infection [PhD thesis] University of Nottingham; UK: 2014. [Accessed April 19, 2018]. Available from: .
    1. National Institute for Health and Care Excellence (NICE) Infection control Quality standards and indicators. Briefing paper. 2013. [Accessed April 19, 2018]. Available from: .
    1. Lam BC, Lee J, Lau YL. Hand hygiene practices in a neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatrics. 2004;114(5):e565–e571.
    1. Won SP, Chou HC, Hsieh WS, et al. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25(9):742–746.
    1. Zerr DM, Allpress AL, Heath J, Bornemann R, Bennett E. Decreasing hospital-associated rotavirus infection: a multidisciplinary hand hygiene campaign in a children’s hospital. Pediatr Infect Dis J. 2005;24(5):397–403.
    1. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control. 2005;33(7):392–397.
    1. Johnson PD, Martin R, Burrell LJ, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust. 2005;183(10):509–514.
    1. Williams L, Rycroft-Malone J, Burton CR. Implementing best practice in infection prevention and control. A realist evaluation of the role of intermediaries. Int J Nurs Stud. 2016;60:156–167.
    1. Jackson C, Lowton K, Griffiths P. Infection prevention as “a show”: a qualitative study of nurses’ infection prevention behaviours. Int J Nurs Stud. 2014;51(3):400–408.
    1. Edwards R, Charani E, Sevdalis N, et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis. 2012;12(4):318–329.
    1. Sax H, Allegranzi B, Uçkay I, Larson E, Boyce J, Pittet D. ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect. 2007;67(1):9–21.
    1. Wisniewski MF, Kim S, Trick WE, Welbel SF, Weinstein RA. Chicago Antimicrobial Resistance Project. Effect of education on hand hygiene beliefs and practices: a 5-year program. Infect Control Hosp Epidemiol. 2007;28(1):88–91.
    1. Santana SL, Furtado GH, Coutinho AP, Medeiros EA. Assessment of healthcare professionals’ adherence to hand hygiene after alcohol-based hand rub introduction at an intensive care unit in São Paulo, Brazil. Infect Control Hosp Epidemiol. 2007;28(3):365–367.
    1. Roberge RJ. Face shields for infection control: A review. J Occup Environ Hyg. 2016;13(4):235–242.
    1. Bhimji SS, Whitten R. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; Jan, 2018. [Accessed September 3, 2018]. Needlestick. [Updated 2018 Mar 14] Available from:
    1. The University of California [webpage on the Internet] Personal Protective Equipment (PPE). Environmental Health & Safety. 2017. [Accessed May 25, 2018]. Available from: .
    1. Fernstrom A, Goldblatt M. Aerobiology and its role in the transmission of infectious diseases. J Pathog. 2013;2013:493960.
    1. Institute of Medicine (US) Committee on Personal Protective Equipment for Healthcare Personnel to Prevent Transmission of Pandemic Influenza and Other Viral Respiratory Infections Current research issues 1 . Introduction. In: Larson EL, Liverman CT, editors. Preventing Transmission of Pandemic Influenza and Other Viral Respiratory Diseases: Personal Protective Equipment for Healthcare Personnel: Update 2010. Washington, DC: National Academies Press (US); 2011. [Accessed May 25, 2018]. Available from:
    1. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(5 Suppl 1):S25–S33.
    1. Otter JA, Yezli S, Salkeld JA, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl):S6–S11.
    1. Weber DJ, Anderson DJ, Sexton DJ, Rutala WA. Role of the environment in the transmission of Clostridium difficile in health care facilities. Am J Infect Control. 2013;41(5 Suppl):S105–S110.
    1. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013;26(4):338–344.
    1. Siani H, Maillard JY. Best practice in healthcare environment decontamination. Eur J Clin Microbiol Infect Dis. 2015;34(1):1–11.
    1. Leas BF, Sullivan N, Han JH, Pegues DA, Kaczmarek JL, Umscheid CA.Environmental Cleaning for the Prevention of Healthcare-Associated Infections Rockville, MD: Agency for Healthcare Research and Quality (US)August2015Report No.: 15-EHC020-EF. AHRQ Comparative Effectiveness Technical Briefs.
    1. Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27(4):665–690.
    1. Han JH, Sullivan N, Leas BF, Pegues DA, Kaczmarek JL, Umscheid CA. Cleaning Hospital Room Surfaces to Prevent Health Care-Associated Infections: A Technical Brief. Ann Intern Med. 2015;163(8):598–607.
    1. Lemmen S, Scheithauer S, Häfner H, Yezli S, Mohr M, Otter JA. Evaluation of hydrogen peroxide vapor for the inactivation of nosocomial pathogens on porous and nonporous surfaces. Am J Infect Control. 2015;43(1):82–85.
    1. Lane HJ, Blum N, Fee E. Oliver Wendell Holmes (1809-1894) and Ignaz Philipp Semmelweis (1818–1865): preventing the transmission of puerperal fever. Am J Public Health. 2010;100(6):1008–1009.
    1. Dunn PM. Oliver Wendell Holmes (1809-1894) and his essay on puerperal fever. Arch Dis Child Fetal Neonatal Ed. 2007;92(4):F325–F327.
    1. WHO . WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. Geneva: WHO; 2009. [Accessed April 20, 2018]. 4. Historical perspective on hand hygiene in health care. Available from:
    1. Mathur P. Hand hygiene: back to the basics of infection control. Indian J Med Res. 2011;134(5):611–620.
    1. Cutter IS, Viets HR. A Short History of Midwifery. Philadelphia; London: W. B. Saunders Company; 1964. p. 99.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅